2020-03-17 07:03:30 REGN Regeneron
Sanofi
03/17/20 03/1707:03 03/17/2007:03 | Regeneron announces advances in novel COVID-19 antibody programRegeneron announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that can be administered as prophylaxis before exposure to the SARS-CoV-2 virus or as treatment for those already infected. Regeneron scientists have now isolated hundreds of virus-neutralizing, fully human antibodies from the company's VelocImmune mice, which have been genetically-modified to have a human immune system. Regeneron has also isolated antibodies from humans who have recovered from COVID-19, in order to maximize the pool of potentially potent antibodies. From this large pool of candidates, Regeneron will select the top two antibodies for a 'cocktail' treatment based on potency and binding ability to the SARS-CoV-2 spike protein, as well as other desirable qualities. Using a multi-antibody approach allows for targeting of different parts of the virus and may help protect against multiple viral variants. Regeneron previously used these technologies to rapidly develop a successful treatment for Ebola virus infection, which is currently under review by the U.S. FDA. In order to meet the pressing public health need, Regeneron is applying its VelociMab technology to prepare manufacturing-ready cell lines as lead antibodies are selected, so that clinical-scale production can begin immediately. The company is working toward the goal of producing hundreds of thousands of prophylactic doses per month by the end of summer and hopes to have smaller quantities available for initial clinical testing at the beginning of the summer. The company is working with the U.S. Health & Human Services' Biomedical Advanced Research and Defense Authority to increase capacity even further. "Our three decades of investment in our VelociSuite antibody technologies, which accelerate and improve the traditional drug discovery process, have hopefully prepared us for this critical time and to meet this important challenge," said George D. Yancopoulos, M.D., Ph.D., Co-founder, President and Chief Scientific Officer of Regeneron. "Given the tremendous interest and concern around the COVID-19 pandemic, we will be providing regular and transparent updates on our discovery and development programs. I want to recognize our incredible team, which is working around the clock to develop needed solutions to this global health crisis." All coronaviruses have a single glycoprotein on the virus surface called the spike protein, which is the protein on the virus cell surface that binds to the host cell and is required for infectivity. Regeneron's SARS-CoV-2 antibodies will target the spike protein in order to block its interaction with the host cell, and thus neutralize the virus. Regeneron
Sanofi
|
|
---|---|---|
|
Options
|
Chegg put volume heavy and directionally bearish »
11:55 03/05/21 03/0511:55 03/05/2111:55
CHGG
Chegg
Bearish flow noted in… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
VW sees boosting share of all-electric deliveries in Europe to over 70% by 2030 »
11:54 03/05/21 03/0511:54 03/05/2111:54
VWAGY
Volkswagen
Volkswagen said that, as… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
U.S., EU reach deal to suspend Boeing-Airbus tariffs, Bloomberg says »
11:52 03/05/21 03/0511:52 03/05/2111:52
EADSY
Airbus
Boeing
The European Union and… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Nuvista Energy price target raised to C$3 from C$1.75 at Desjardins »
11:45 03/05/21 03/0511:45 03/05/2111:45
NUVSF
Nuvista Energy
Desjardins analyst Chris… Story temporarily locked. ShowHide Related Items >><<
|
Options
|
Bank of America call volume above normal and directionally bullish »
11:45 03/05/21 03/0511:45 03/05/2111:45
BAC
Bank of America
Bullish option flow… Story temporarily locked. ShowHide Related Items >><<
|
General news
| The U.S. trade deficit… Story temporarily locked. |
Recommendations
|
MEG Energy price target raised to C$7 from C$4 at Desjardins »
11:38 03/05/21 03/0511:38 03/05/2111:38
MEGEF
MEG Energy
Desjardins analyst Justin… Story temporarily locked. ShowHide Related Items >><<
|
Options
|
Twitter put volume heavy and directionally bearish »
11:35 03/05/21 03/0511:35 03/05/2111:35
TWTR
Bearish flow noted in… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Clearwater Paper management to meet virtually with KeyBanc »
11:33 03/05/21 03/0511:33 03/05/2111:33
CLW
Clearwater Paper
Virtual Meeting to be… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Laurentian Bank price target raised to C$41 from C$33 at Desjardins »
11:32 03/05/21 03/0511:32 03/05/2111:32
LRCDF
Laurentian Bank
Desjardins analyst Doug… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
SM Energy management to meet virtually with KeyBanc »
11:32 03/05/21 03/0511:32 03/05/2111:32
SM
SM Energy
Virtual Meeting to be… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Cominar REIT price target raised to C$9.75 from C$9 at Desjardins »
11:31 03/05/21 03/0511:31 03/05/2111:31
CMLEF
Cominar REIT
Desjardins analyst… Story temporarily locked. ShowHide Related Items >><<
|
Syndicate
|
VPC Impact Acquisition Holdings II opens at $10, IPO priced at $10 »
11:31 03/05/21 03/0511:31 03/05/2111:31
VPCB
VPC Impact Acquisition Holdings II
VPC Impact Acquisition… Story temporarily locked. |
Hot Stocks
|
Applied UV jumps after subsidiary touts LEDs 'proven to kill' Covid »
11:25 03/05/21 03/0511:25 03/05/2111:25
AUVI
Applied UV
SteriLumen, a wholly… SteriLumen, a wholly owned subsidiary of Applied UV (AUVI), said on Twitter: "The LEDs in our devices have been proven to kill Coronavirus in seconds." Following the tweet, shares of Applied UV jumped 15% to $8.95. In February, SteriLumen acquired Akida, makers of the Airocide product line which was developed with NASA to address air-borne pathogens and bring air purification technology to fight against coronavirus. Reference Link ShowHide Related Items >><<
|
General news
| FX Action: USD-JPY pulled… Story temporarily locked. |
Options
|
21st Century Fox call volume above normal and directionally bullish »
11:25 03/05/21 03/0511:25 03/05/2111:25
FOXA
Fox Corp.
Bullish option flow… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Cowen Internet & restaurants analysts to hold analyst/industry conference call »
11:25 03/05/21 03/0511:25 03/05/2111:25
GRUB
GrubHub
Uber
Internet & New Media… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Cowen alternative enery analyst to hold analyst/industry conference call »
11:25 03/05/21 03/0511:25 03/05/2111:25
Alternative Energy… Story temporarily locked. |
Conference/Events
|
UBS consumer goods analyst to hold an analyst/industry conference call »
11:25 03/05/21 03/0511:25 03/05/2111:25
NKE
Nike
Adidas
Consumer Goods Analyst… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Vincera Pharma to host business news update conference call »
11:25 03/05/21 03/0511:25 03/05/2111:25
VINC
Vincera Pharma
Management, along with… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Boyd Group Services price target raised to C$250 from C$235 at Desjardins »
11:24 03/05/21 03/0511:24 03/05/2111:24
BYDGF
Boyd Group Services
Desjardins analyst David… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Athabasca Oil price target raised to C$0.40 from C$0.20 at Desjardins »
11:23 03/05/21 03/0511:23 03/05/2111:23
ATHOF
Athabasca Oil
Desjardins analyst Justin… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
U.S. and EU reach deal to suspend Boeing-Airbus tariffs, Bloomberg says »
11:22 03/05/21 03/0511:22 03/05/2111:22
BA
Boeing
Airbus
The U.S. and EU are said… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Artis REIT price target raised to C$11.50 from C$11 at Desjardins »
11:22 03/05/21 03/0511:22 03/05/2111:22
ARESF
Artis REIT
Desjardins analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
NFI Group price target raised to C$35 from C$34 at Scotiabank »
11:19 03/05/21 03/0511:19 03/05/2111:19
NFYEF
NFI Group
Scotiabank analyst Mark… Story temporarily locked. ShowHide Related Items >><<
|